|
|
SPOT ON
|
|
Sitagliptin and TECOS: how a negative trial becomes positive
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Heparin bridging in anticoagulation with coumarins
|
|
|
NEW ON THE MARKET
|
|
MAO-B inhibitor safinamide (XADAGO) in PARKINSON's disease
Antidepressant vortioxetine (BRINTELLIX)
Ivermectin cream (SOOLANTRA) for rosacea
|
|
|
a-t IN BRIEF
|
|
New instructions on the practical application of adrenaline auto-injectors
Diabetes research dominated by a small group of authors with conflicts of interest
Independent patient information soon by a service provider for health insurance funds and pharmaceutical industry?
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Pancreatitis with roflumilast (DAXAS)
|
|
|
e a-t IN INTERNET
|
|
Adverse drug reaction missing from product information: sepsis with vemurafenib (ZELBORAF)
|
|